vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and First Foundation Inc. (FFWM). Click either name above to swap in a different company.

First Foundation Inc. is the larger business by last-quarter revenue ($48.4M vs $38.9M, roughly 1.2× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs -97.9%, a 122.5% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs 81.3%). CODEXIS, INC. produced more free cash flow last quarter ($19.6M vs $-35.2M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -2.7%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.

CDXS vs FFWM — Head-to-Head

Bigger by revenue
FFWM
FFWM
1.2× larger
FFWM
$48.4M
$38.9M
CDXS
Growing faster (revenue YoY)
FFWM
FFWM
+340.3% gap
FFWM
421.7%
81.3%
CDXS
Higher net margin
CDXS
CDXS
122.5% more per $
CDXS
24.7%
-97.9%
FFWM
More free cash flow
CDXS
CDXS
$54.8M more FCF
CDXS
$19.6M
$-35.2M
FFWM
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-2.7%
FFWM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
FFWM
FFWM
Revenue
$38.9M
$48.4M
Net Profit
$9.6M
$-8.0M
Gross Margin
94.8%
Operating Margin
27.1%
-97.5%
Net Margin
24.7%
-97.9%
Revenue YoY
81.3%
421.7%
Net Profit YoY
192.5%
43.0%
EPS (diluted)
$0.13
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
FFWM
FFWM
Q4 25
$38.9M
$48.4M
Q3 25
$8.6M
$63.6M
Q2 25
$15.3M
$51.4M
Q1 25
$7.5M
$71.4M
Q4 24
$21.5M
$9.3M
Q3 24
$12.8M
$9.2M
Q2 24
$8.0M
$57.5M
Q1 24
$17.1M
$51.1M
Net Profit
CDXS
CDXS
FFWM
FFWM
Q4 25
$9.6M
$-8.0M
Q3 25
$-19.6M
$-146.3M
Q2 25
$-13.3M
$-7.7M
Q1 25
$-20.7M
$6.9M
Q4 24
$-10.4M
$-14.1M
Q3 24
$-20.6M
$-82.2M
Q2 24
$-22.8M
$3.1M
Q1 24
$-11.5M
$793.0K
Gross Margin
CDXS
CDXS
FFWM
FFWM
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
FFWM
FFWM
Q4 25
27.1%
-97.5%
Q3 25
-220.3%
-92.7%
Q2 25
-83.9%
-21.1%
Q1 25
-271.6%
8.8%
Q4 24
-34.2%
-247.7%
Q3 24
-129.0%
-1276.7%
Q2 24
-284.9%
4.6%
Q1 24
-69.6%
-0.2%
Net Margin
CDXS
CDXS
FFWM
FFWM
Q4 25
24.7%
-97.9%
Q3 25
-228.1%
-230.1%
Q2 25
-86.6%
-15.0%
Q1 25
-274.3%
9.7%
Q4 24
-48.4%
-152.2%
Q3 24
-160.8%
-896.9%
Q2 24
-285.2%
5.4%
Q1 24
-67.4%
1.6%
EPS (diluted)
CDXS
CDXS
FFWM
FFWM
Q4 25
$0.13
$-0.09
Q3 25
$-0.22
$-1.78
Q2 25
$-0.16
$-0.09
Q1 25
$-0.25
$0.08
Q4 24
$-0.12
$-0.24
Q3 24
$-0.29
$-1.23
Q2 24
$-0.32
$0.05
Q1 24
$-0.16
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
FFWM
FFWM
Cash + ST InvestmentsLiquidity on hand
$78.2M
$1.6B
Total DebtLower is stronger
$40.1M
Stockholders' EquityBook value
$50.5M
$912.6M
Total Assets
$147.8M
$11.9B
Debt / EquityLower = less leverage
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
FFWM
FFWM
Q4 25
$78.2M
$1.6B
Q3 25
$58.7M
$1.7B
Q2 25
$66.3M
$1.1B
Q1 25
$59.8M
$1.0B
Q4 24
$73.5M
$1.0B
Q3 24
$90.3M
$1.1B
Q2 24
$73.2M
$1.4B
Q1 24
$85.5M
$1.6B
Total Debt
CDXS
CDXS
FFWM
FFWM
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CDXS
CDXS
FFWM
FFWM
Q4 25
$50.5M
$912.6M
Q3 25
$38.5M
$917.9M
Q2 25
$55.6M
$1.1B
Q1 25
$49.6M
$1.1B
Q4 24
$66.9M
$1.1B
Q3 24
$73.4M
$1.1B
Q2 24
$61.4M
$933.2M
Q1 24
$79.3M
$928.7M
Total Assets
CDXS
CDXS
FFWM
FFWM
Q4 25
$147.8M
$11.9B
Q3 25
$124.0M
$11.9B
Q2 25
$138.2M
$11.6B
Q1 25
$128.9M
$12.6B
Q4 24
$149.0M
$12.6B
Q3 24
$148.2M
$13.4B
Q2 24
$132.0M
$13.7B
Q1 24
$149.6M
$13.6B
Debt / Equity
CDXS
CDXS
FFWM
FFWM
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
FFWM
FFWM
Operating Cash FlowLast quarter
$20.1M
$-31.9M
Free Cash FlowOCF − Capex
$19.6M
$-35.2M
FCF MarginFCF / Revenue
50.3%
-72.8%
Capex IntensityCapex / Revenue
1.3%
6.9%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$-45.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
FFWM
FFWM
Q4 25
$20.1M
$-31.9M
Q3 25
$-7.7M
$9.2M
Q2 25
$-18.0M
$-16.3M
Q1 25
$-13.8M
$-552.0K
Q4 24
$-16.5M
$-8.7M
Q3 24
$-13.0M
$14.2M
Q2 24
$-12.2M
$-9.1M
Q1 24
$-7.8M
$7.2M
Free Cash Flow
CDXS
CDXS
FFWM
FFWM
Q4 25
$19.6M
$-35.2M
Q3 25
$-7.9M
$8.6M
Q2 25
$-20.5M
$-16.7M
Q1 25
$-15.1M
$-2.5M
Q4 24
$-18.2M
$-11.4M
Q3 24
$-14.0M
$13.4M
Q2 24
$-12.6M
$-9.4M
Q1 24
$-8.9M
$5.9M
FCF Margin
CDXS
CDXS
FFWM
FFWM
Q4 25
50.3%
-72.8%
Q3 25
-91.7%
13.5%
Q2 25
-133.6%
-32.4%
Q1 25
-199.6%
-3.5%
Q4 24
-85.0%
-123.5%
Q3 24
-109.0%
146.2%
Q2 24
-157.5%
-16.3%
Q1 24
-52.2%
11.6%
Capex Intensity
CDXS
CDXS
FFWM
FFWM
Q4 25
1.3%
6.9%
Q3 25
2.1%
1.0%
Q2 25
16.4%
0.8%
Q1 25
16.7%
2.8%
Q4 24
8.3%
29.4%
Q3 24
7.8%
9.0%
Q2 24
5.0%
0.4%
Q1 24
6.6%
2.5%
Cash Conversion
CDXS
CDXS
FFWM
FFWM
Q4 25
2.09×
Q3 25
Q2 25
Q1 25
-0.08×
Q4 24
Q3 24
Q2 24
-2.96×
Q1 24
9.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons